PHARMARX LTD
- 47749SIC 47749
- 47990Other retail sale not in stores, stalls or markets
- 86900Other human health activities
Opportunity 71/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (58/100).
Data confidence
Overall: medium (73/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 |
|---|---|
| Average employees | 12 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (21 events)Click to expand
- 2025-12-23📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-02-10📄accounts-amended-with-accounts-type-total-exemption-fullaccounts · AAMD
- 2024-12-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-12-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-04-18📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2023-04-18📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2022-12-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-12-15📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-03-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-12-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-12-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-03-27📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2018-03-27📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2018-03-27📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2018-03-27📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2018-03-23📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-02-09➖BOYD, Tony resigneddirector
- 2017-03-21🏢Company incorporatedAs PHARMARX LTD
- 2017-03-21➕KADIR, Nazmul appointeddirector
- 2017-03-21➕NAKIB, Ibrahim appointeddirector
- 2017-03-21➕BOYD, Tony appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Ibrahim Nakib Individual · British · DOB 04/1991 · age 35 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control · trust interest · firm interest | 21/03/2017 |
Mr Nazmul Kadir Individual · British · DOB 01/1994 · age 32 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control · trust interest · firm interest | 21/03/2017 |
1 historic (ceased) PSC
- Mr Tony Boydceased 22/03/2018· 25-50% shares · 25-50% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Retail · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| POUNCE PADEL LTD→ SC831383 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| PRETTY PICKLED LTD→ SC692693 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| PRIME OFFERS LIMITED→ SC687874 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| PROGIT LIMITED→ SC641194 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| PROHEALTH CLINICS LTD.→ SC428845 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| PROIECTUM LTD→ SC863836 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| PS RETIAL LIMITED→ SC817899 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| Q STORE LIMITED→ SC242279 · est 2003 · no financials extracted | — | — | — | — | 23y | — | — |
| QIROX LIMITED→ SC832868 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| QMTJ LIMITED→ SC811185 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| RADHE KISHORI LTD→ SC873595 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| RAGAMUFFIN EDINBURGH LIMITED→ SC800054 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 1 resigned)
Click a director name to see their full track record across all companies.